Wave Life Sciences Ltd. — Director's Dealing 2016

Aug 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2016-08-19

Reporting Person: GUERCIOLINI ROBERTO (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-19	Ordinary Shares	M	5000	$2.47	Acquired	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-19	Share Option (Right to Buy)	$2.47	M	5000	Disposed	2025-03-22	Ordinary Shares (5000)	Direct

Footnotes

F1: The option represented a right to purchase a total of 108,617 ordinary shares, 25% of which became exercisable on March 10, 2016, which was the first anniversary on which the option was granted, and the remaining shares vest in 36 equal monthly installments thereafter.